ADCYAP1 and airway hyperresponsiveness: In another rat model, in vanadate-induced airway hyperresponsiveness, PACAP inhalation alleviated the increase in bronchial resistance, reduced the increased inflammatory chemokine, and cytokine release and improved the antioxidant status, also pointing to the potential of PACAP treatment in inflammatory and allergic respiratory conditions (80).